HIVETECHNOLOGY CONSULTANCY
Institutional Access
PORTFOLIO

A Living Portfolio of State, Evidence and Value

Public records show what each project is and where it stands. Controlled access can reveal deeper economics, evidence and institutional material.

PORTFOLIO DOCTRINE

Current state first. Claims second.

Each record distinguishes lifecycle state from evidence state, economics from market claims, and public representation from controlled diligence. Values can evolve as implementation, validation and operating evidence improve.

Inclusion never collapses co-owner, contributor, founder or third-party rights into one ownership claim.

VISIBLE8
RECORDPROJECTLIFECYCLEEVIDENCECURRENT MILESTONE
01 / IV
Automotive TechnologyIVI Motors
Held Historical implementation

Technical and commercial asset review before any reactivation decision.

 02 / PG
Mobility EngineeringIVI Pragati
Developing Approved architecture

IP strategy, independent engineering review and physical-prototype definition.

 03 / MC
Digital WellnessMercilia
Operating Proven in use

Selective distribution, licensing and partnership development.

 04 / MM
Authored KnowledgeThe Maverick Method
Active Published

Arabic edition, distribution and selected derivative applications.

 05 / VL
Commerce & DistributionValueré
Operating Proven in use

GCC B2B distribution and recurring commercial relationships.

 06 / VX
Social TechnologyVexel
Developing Implemented

Product coherence, technical hardening and controlled real-event validation.

 07 / WK
Workforce SystemsWorkr
Developing Implemented

Controlled pilot preparation and operating validation.

 08 / XD
Health TechnologyX-Diagnostics
Developing Demonstrated

Product experience consolidation and production reconciliation.
ECONOMIC DISCIPLINE

Replacement value is not automatically market valuation.

Hive keeps reproduction/build value, indicative valuation, capital deployed and next-milestone requirements distinct. Controlled reviewers see the basis attached to each number rather than an unexplained headline.

01Replacement / reproduction value

What comparable development may cost to reproduce today.

02Hive indicative value

An owner-approved internal project estimate with its own basis, date and limitations.

03Operating evidence

Real implementation, validation, revenue or use can change the appropriate methodology.

PUBLIC

Useful without over-disclosure

  • Purpose and sector
  • Lifecycle and evidence state
  • Current milestone
  • Approved public engagement route
CONTROLLED

Diligence by authorization

  • Reproduction and valuation records
  • Detailed evidence and documents
  • Capital requirement and current ask
  • Relationship-specific disclosure
Institutional Access